Panayiota G. Michalopoulou

Author

Also Known As

P Michalopoulou, P. G. Michalopoulou, P. Michalopoulou, P.G. Michalopoulou, Panayiota G Michalopoulou, Panayiota G. Michalopoulou, Panayiota Michalopoulou

Publications

1.6K

Citations

H-Index

Concepts

All Affiliations

King's College London National and Kapodistrian University of Athens University General Hospital Attikon University of Manchester University College London

About

Panayiota G. Michalopoulou is an author at King's College London specializing in social sciences, psychiatry, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Social Sciences	7	7	383
2	Medicine	6	6	351
3	Cognitive Science	2	2	59
4	Health Sciences	1	1	20
5	Nursing	1	1	27

Panayiota G. Michalopoulou

Publications

Citations

H-Index

Page 1

	Year	Citations
Hospital Anxiety and Depression Scale (HADS): validation in a Greek general hospital sample Ioannis Michopoulos, Athanasios Douzenis, C. Kalkavoura, Annals of General Psychiatry	2008	374
Investigation of serum BDNF levels in drug-naive patients with schizophrenia Emmanouil� Rizos, Ioannis Rontos, E. Laskos, Progress in Neuro-Psychopharmacology and Biological Psychiatry Serum Bdnf LevelsPsychiatryPsychotic DisorderMedicinePsychopharmacology	2008	118
Association of serum BDNF levels with hippocampal volumes in first psychotic episode drug-naive schizophrenic patients Emmanouil� Rizos, M. Papathanasiou, Panayiota G. Michalopoulou, Schizophrenia Research PsychiatryPsychotic DisorderMedicinePsychotropic MedicationHippocampal Volumes	2011	92
Modafinil combined with cognitive training: Pharmacological augmentation of cognitive training in schizophrenia Panayiota G. Michalopoulou, Shôn Lewis, Richard Drake, European Neuropsychopharmacology Psychoactive DrugPsychiatryPsychotic DisorderMedicinePsychotropic Medication	2015	57
Facial fear processing and psychotic symptoms in schizophrenia: functional magnetic resonance imaging study Panayiota G. Michalopoulou, Simon Surguladze, Lucy Morley, The British Journal of Psychiatry	2008	56
Association of Serum Brain-Derived Neurotrophic Factor and Duration of Untreated Psychosis in First-Episode Patients with Schizophrenia Emmanouil� Rizos, Panayiota G. Michalopoulou, Nikolaos Siafakas, Neuropsychobiology	2010	50
Modafinil and cognitive enhancement in schizophrenia and healthy volunteers: the effects of test battery in a randomised controlled trial Jane Lees, Panayiota G. Michalopoulou, Shôn Lewis, Psychological Medicine	2017	48
Modafinil combined with cognitive training is associated with improved learning in healthy volunteers – A randomised controlled trial James Gilleen, Panayiota G. Michalopoulou, Abraham Reichenberg, European Neuropsychopharmacology Improved LearningCognitive ScienceCognitive PerformanceHealthy VolunteersCognition	2014	39
Calibration and cross-validation of MCCB and CogState in schizophrenia Jane Lees, Eve Applegate, Richard Emsley, Psychopharmacology PsychiatryPsychotic DisorderSchizophreniaNeuroimagingSocial Sciences	2015	36
Cognitive decline and dementia in elderly medical inpatients remain underestimated and underdiagnosed in a recently established university general hospital in Greece Athanasios Douzenis, Ioannis Michopoulos, Rossetos Gournellis, Archives of Gerontology and Geriatrics NursingUniversity General HospitalAlzheimer's DiseaseElderly Medical InpatientsPsychiatry	2009	27

Page 1